The alternative pathway of T cell activation: Biology, pathophysiology, and perspectives for immunopharmacology
- 1 January 1989
- journal article
- review article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 50 (1) , S133-S139
- https://doi.org/10.1016/0090-1229(89)90120-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Purified lymphocyte function‐associated antigen‐3 and T11 target structure are active in CD2‐mediated T cell stimulationEuropean Journal of Immunology, 1987
- Two antigen-independent adhesion pathways used by human cytotoxic T-cell clonesNature, 1986
- T cell stimulation via the erythrocyte receptor. Synergism between monoclonal antibodies and phorbol myristate acetate without changes of free cytoplasmic Ca++ levels.The Journal of Experimental Medicine, 1986
- Modulation of surface T11 molecules induced by monoclonal antibodies: analysis of the functional relationship between antigen‐dependent and antigen‐independent pathways of human T cell activationEuropean Journal of Immunology, 1986
- The cell surface molecule recognized by the erythrocyte receptor of T lymphocytes. Identification and partial characterization using a monoclonal antibody.The Journal of Experimental Medicine, 1985
- Phytohaemagglutinin activation of T cells through the sheep red blood cell receptorNature, 1985
- Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptorNature, 1983
- Cell-mediated immune deficiency in Hodgkin's diseaseImmunology Today, 1982
- Phenomenon of human T cells rosetting with sheep erythrocytes analyzed with monoclonal antibodies. "Modulation" of a partially hidden epitope determining the conditions of interaction between T cells and erythrocytesThe Journal of Experimental Medicine, 1982
- International Union of Immunological Societies (IUIS), report-July 1974Clinical Immunology and Immunopathology, 1975